Edwards Lifesciences (EW) Profit After Tax (QoQ) (2009 - 2026)
Edwards Lifesciences (EW) Profit After Tax (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 533.44% |
| Dec 31, 2025 | -79.35% |
| Sep 30, 2025 | -12.19% |
| Jun 30, 2025 | -8.83% |
| Mar 31, 2025 | 5.39% |
| Dec 31, 2024 | -88.76% |
| Sep 30, 2024 | 740.93% |
| Jun 30, 2024 | 3.99% |
| Mar 31, 2024 | 5.37% |
| Dec 31, 2023 | -13.19% |
| Sep 30, 2023 | 25.60% |
| Jun 30, 2023 | -10.28% |
| Mar 31, 2023 | 69.83% |
| Dec 31, 2022 | -41.63% |
| Sep 30, 2022 | -15.48% |
| Jun 30, 2022 | 8.78% |
| Mar 31, 2022 | 11.42% |
| Dec 31, 2021 | -1.41% |
| Sep 30, 2021 | 2,557.03% |
| Jun 30, 2021 | 213.27% |